Biodexa Pharmaceuticals Plc (BDRX)
NASDAQ: BDRX · Real-Time Price · USD
5.04
-0.05 (-0.98%)
At close: Dec 5, 2025, 4:00 PM EST
6.49
+1.45 (28.77%)
After-hours: Dec 5, 2025, 7:59 PM EST

Biodexa Pharmaceuticals Revenue

Biodexa Pharmaceuticals had revenue of 13.50K GBP in the half year ending June 30, 2025.

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
13
Market Cap
3.12M USD

Revenue Chart

* This company reports financials in GBP.

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 2024---
Dec 31, 2023381.00K-318.00K-45.49%
Dec 31, 2022699.00K676.81K3,050.21%
Feb 28, 202222.19K-555.81K-96.16%
Dec 31, 2021578.00K-1.72M-74.86%
Feb 28, 20212.30M1.96M570.22%
Dec 31, 2020343.00K-331.00K-49.11%
Dec 31, 2019674.00K-1.26M-65.22%
Dec 31, 20181.94M949.00K95.96%
Dec 31, 2017989.00K-334.00K-25.25%
Dec 31, 20161.32M-52.00K-3.78%
Dec 31, 20151.38M1.22M775.80%
Dec 31, 2014157.00K10.00K6.80%
Dec 31, 2013147.00K--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
UnitedHealth Group435.16B
Johnson & Johnson92.15B
Merck & Co.64.24B
AbbVie59.64B
Eli Lilly and Company59.42B
AstraZeneca58.13B
Novartis AG56.37B
Novo Nordisk49.58B
Revenue Rankings